Novel Target for Diagnosing and Treating Depression and Alzheimer Disease

We are looking for a partnership to achieve two goals:

1. Validation of our animal model with results using human blood samples taken from clinical trials using subjects suffering progressive Alzheimer disease and Depression

2. Assistance with targetting Amyloid Precursor Protein fragments identified in causing both increased and decreased levels of monoamine oxidase-A (ie. generation of soluble peptides and antibodies)